STEM-Talk cover image

Episode 132: Martin Kulldorff discusses vaccines, lockdowns, school closings and the global response to COVID-19

STEM-Talk

CHAPTER

Drug Safety and Risk Management Advisory Committee

Since a 20 18, you've been a member of the f d a's drug safety and risk management advisory committee. Can you talk a little bit about this work and how it interacts with the agency? "It is the way to help the fda, to get outside independent views on whether a specific drug should be approved or not"

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner